Avantax Planning Partners, Inc. I Bio, Inc. Transaction History

Avantax Planning Partners, Inc.

  • $3.1 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
BUY
$0.3 - $0.61 $30,000 - $61,000
100,000 Added 400.0%
125,000 $54,000
Q4 2021

Jan 28, 2022
BUY
$0.55 - $1.04 $8,250 - $15,600
15,000 Added 150.0%
25,000 $14,000
Q2 2021

Aug 10, 2021
BUY
$1.22 - $1.65 $12,200 - $16,500
10,000 New
10,000 $15,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Avantax Planning Partners, Inc. Portfolio

Follow Avantax Planning Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email